Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report by Canadean

VIEWS: 4 PAGES: 30

Canadean's "Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, mergers & acquisitions, key facts, information on products and services, details of locations and subsidiaries.

More Info
									Australian Pharmaceutical Industries Limited

_________________________________________________________________________________



Australian Pharmaceutical                                                        Financial Snapshot

Industries Limited                                                               Operating Performance

Fast Facts                                                                       The company reported revenue of US$3,143.02
                                                                                 million during the fiscal year 2011 (2011). The
                                                                                 company's revenue grew at a CAGR of 9.24% during
Headquarters Address                 11 Grand Avenue, Camellia, 2142,Australia
                                                                                 2007–2011, with an annual decline of 7.56% over
                                                                                 2010. In 2011, the company recorded an operating
Telephone                            + 61 2 88442000
                                                                                 margin of -0.19%, as against 1.57% in 2010.
Fax                                  + 61 2 88442896
                                                                                 Revenue and Margins
Website                              www.api.net.au

Ticker Symbol, Stock Exchange        API, Australian Stock Exchange

Number of Employees                  5,105

Fiscal Year End                      August

Revenue (in US$ million)             3,143.02

Revenue (in AUD million)             3,425.89




SWOT Analysis

Strengths                            Weaknesses

Presence across the value chain      Limited geographic presence

Strong presence in pharmacy market   Weak financial performance

Wide product and service portfolio

Opportunities                        Threats

Ageing population                    Rising labor wages

Business expansions                  Stringent regulations

                                     Strong initiatives by competitors




___________________________________________________________________________________________

Australian Pharmaceutical Industries Limited - SWOT                                                                 Page 1
Profile
Australian Pharmaceutical Industries Limited

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................12
      2.2.4       Solvency ..........................................................................................................................................................13
    2.3       Key Competitors ...................................................................................................................................................14
3     Mergers & Acquisitions and Partnerships ........................................................................................... 15
    3.1       M&A and Partnerships Strategy ...........................................................................................................................15
4     SWOT Analysis ...................................................................................................................................... 17
    4.1       SWOT Analysis - Overview ..................................................................................................................................17
    4.2       Strengths ..............................................................................................................................................................17
    4.3       Weaknesses .........................................................................................................................................................17
    4.4       Opportunities ........................................................................................................................................................18
    4.5       Thre
								
To top